丹参酮ⅡA磺酸钠通过诱导衰老抑制诱导性深部子宫内膜异位症小鼠的纤维化
研究在Balb/C雌性小鼠诱导深部子宫内膜异位症模型中,前瞻性随机分为低剂量STS、高剂量STS和惰性溶媒对照组治疗2周。STS治疗显著降低病灶重量、抑制病灶纤维化并改善痛觉过敏,可能通过激活p53、Sav1和CCN1诱导细胞衰老实现。STS可能是治疗子宫内膜异位症有前景的化合物。
要点
- STS治疗显著降低小鼠子宫内膜异位病灶重量并抑制病灶纤维化。
- STS改善痛觉过敏,可能通过激活p53、Sav1和CCN1诱导细胞衰老。
- STS显著降低血浆P-选择素和透明质酸浓度,可能减少病灶血小板聚集。
核心结论
- STS似乎是治疗子宫内膜异位症有前景的化合物。
- 结果提示衰老可能限制病灶进展和纤维化,靶向衰老通路可能具有理想的治疗潜力。
研究设计与样本
- 前瞻性随机动物实验,在雌性Balb/C小鼠诱导深部子宫内膜异位症。
- 小鼠随机分为三组:低剂量STS组、高剂量STS组和惰性溶媒对照组,治疗2周。
- 所有小鼠治疗后处死,切除并收集病灶。
主要发现
- STS治疗显著降低病灶重量、阻止病灶纤维化并改善痛觉过敏。
- STS seemingly通过激活p53、Sav1和CCN1并抑制HAS2、survivin和GM-CSF诱导细胞衰老,导致凋亡增加和替代激活巨噬细胞病灶浸润减少。
- STS治疗显著降低血浆P-选择素和透明质酸浓度,可能减少病灶血小板聚集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does sodium tanshinone IIA sulfonate (STS) induce cellular senescence in endometriotic lesions and thus restrict lesional development and fibrogenesis in a recently established mouse model of deep endometriosis? DESIGN: Prospective randomized animal experiment in which deep endometriosis was induced in female Balb/C mice, which were then randomly divided into three groups (low-dose STS, high-dose STS and inert vehicle control) and received treatment for 2 weeks. All mice were then sacrificed and their lesions excised and harvested. Lesion weight was quantified and all lesion samples were subjected to histochemical analysis of the extent of lesional fibrosis by Masson trichrome staining, and of cellular senescence by senescence-associated β-galactosidase (SA-β-gal), along with immunohistochemistry analyses of p53, CCN1, activate Salvador 1 (Sav1), hyaluronan synthase 2 (HAS2), survivin, granulocyte-macrophage colony-stimulating factor (GM-CSF) and CD163-positive M2 macrophages. Plasma P-selectin and hyaluronic acid levels were also quantified. Hotplate testing was also administered before the induction, then before and after treatment. RESULTS: STS treatment resulted in significantly reduced lesion weight, stalled lesional fibrogenesis and improved hyperalgesia, seemingly through the induction of cellular senescence by activating p53, Sav1 and CCN1 while suppressing HAS2, survivin and GM-CSF, resulting in increased apoptosis and reduced lesional infiltration of alternatively activated macrophages. In addition, STS treatment significantly reduced the plasma concentration of P-selectin and hyaluronic acid, possibly leading to reduced lesional platelet aggregation. CONCLUSIONS: STS appears to be a promising compound for treating endometriosis. The results suggest that senescence may restrict lesional progression and fibrogenesis, and targeting the senescence pathway may have desirable therapeutic potential.
引用
- Luo M, Cai X, Yan D, et al. Sodium tanshinone IIA sulfonate restrains fibrogenesis through induction of senescence in mice with induced deep endometriosis. Reprod Biomed Online. 2020. PMID: 32651107. doi:10.1016/j.rbmo.2020.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。